Eric A. Wold
Impact in
- Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis
- Catalytic C–H Functionalization Methods
- Synthesis and Catalytic Reactions
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in ⓘ
-
- Receptor Mechanisms and Signaling 7
- Protein Degradation and Inhibitors 3
- Bioactive Natural Diterpenoids Research 3
- Chemical Synthesis and Analysis 2
- Pharmacological Receptor Mechanisms and Effects 2
-
- Chemical synthesis and alkaloids 3
- Co-authors
- Jia Zhou (22 shared papers)Haiying Chen (11 shared papers)Na Ye (7 shared papers)Pei‐Yong Shi (1 shared paper)Zhiqing Liu (8 shared papers)Pingyuan Wang (5 shared papers)Ye Ding (6 shared papers)Bing Tian (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (10 papers)Current Topics in Medicinal Chemistry (3 papers)European Journal of Medicinal Chemistry (2 papers)ACS Chemical Neuroscience (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Eric A. Wold
28 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Organic Chemistry 512
- Hematology 171
- Toxicology 45
- Molecular Biology 900
- Pharmacology 110
Countries citing papers authored by Eric A. Wold
This map shows the geographic impact of Eric A. Wold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Wold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Wold more than expected).
Fields of papers citing papers by Eric A. Wold
This network shows the impact of papers produced by Eric A. Wold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Wold. The network helps show where Eric A. Wold may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric A. Wold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Therapeutic Potential of Spirooxindoles as Antiviral Agents Hit paper breakdown → | 2016 | 412 |
| 2 | 2017 | 235 | |
| 3 | 2016 | 148 | |
| 4 | 2018 | 110 | |
| 5 | 2018 | 100 | |
| 6 | 2020 | 70 | |
| 7 | 2020 | 61 | |
| 8 | 2022 | 44 | |
| 9 | 2015 | 43 | |
| 10 | 2019 | 41 | |
| 11 | 2018 | 37 | |
| 12 | 2021 | 31 | |
| 13 | 2018 | 27 | |
| 14 | 2018 | 26 | |
| 15 | 2019 | 22 | |
| 16 | 2015 | 15 | |
| 17 | 2020 | 15 | |
| 18 | 2019 | 14 | |
| 19 | 2019 | 13 | |
| 20 | 2013 | 10 |
About Eric A. Wold
Eric A. Wold is a scholar working on Molecular Biology, Organic Chemistry, Cellular and Molecular Neuroscience, Public Health, Environmental and Occupational Health and Immunology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (7 papers), Protein Degradation and Inhibitors (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Chemical synthesis and alkaloids (3 papers), Bioactive Natural Diterpenoids Research (3 papers), Neuropeptides and Animal Physiology (3 papers), Chemical Synthesis and Analysis (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). The work is most often cited by research in Organic Chemistry (512 citations), Hematology (171 citations), Toxicology (45 citations), Molecular Biology (900 citations) and Pharmacology (110 citations). Eric A. Wold has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Jia Zhou, Haiying Chen, Na Ye, Pei‐Yong Shi, Zhiqing Liu, Pingyuan Wang, Ye Ding, Bing Tian, Allan R. Brasier and Kathryn A. Cunningham. Their work appears in journals such as Journal of Medicinal Chemistry, Current Topics in Medicinal Chemistry, European Journal of Medicinal Chemistry, ACS Chemical Neuroscience and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.